746694
Last Update Posted: 2015-08-27
Recruiting has ended
Females accepted | 18 Years + |
154 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
The objective of this trial is to study the management of PPE in participants with metastatic ovarian or breast cancer treated with Caelyx, and determine the frequency of use of pharmacological treatment (preventive or therapeutic) for PPE and compliance of educational recommendations for PPE.
Eligibility
Relevant conditions:
Ovarian Neoplasms
Breast Neoplasms
Paresthesia
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov